Related references
Note: Only part of the references are listed.Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
Gonzalo Gutierrez-Garcia et al.
BLOOD (2011)
High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma
Dai Chihara et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab
Paul N. Meyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Role of Functional Imaging in the Management of Lymphoma
Bruce D. Cheson
JOURNAL OF CLINICAL ONCOLOGY (2011)
The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma
P. Ruminy et al.
LEUKEMIA (2011)
Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study
Fabrice Jardin et al.
BLOOD (2010)
Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma
Ludovic Le Dortz et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Benefit of Consolidative Radiation Therapy in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP Chemotherapy
Jack Phan et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma
Reina Watanabe et al.
LEUKEMIA & LYMPHOMA (2010)
Mechanisms of Disease: Aggressive Lymphomas.
Georg Lenz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer
Kyoichi Kaira et al.
CANCER SCIENCE (2009)
[18F]Fluorodeoxyglucose Positron Emission Tomography Correlates With Akt Pathway Activity but Is Not Predictive of Clinical Outcome During mTOR Inhibitor Therapy
Wen Wee Ma et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Prognostic Value of Interim 18F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment at 4 Cycles of Chemotherapy
Emmanuel Itti et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas
Hye Kyung Shim et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome
Maroun Karam et al.
NUCLEAR MEDICINE COMMUNICATIONS (2009)
Relationship Between FDG Uptake and Expressions of Glucose Transporter Type 1, Type 3, and Hexokinase-II in Reed-Sternberg Cells of Hodgkin Lymphoma
Hye Kyung Shim et al.
ONCOLOGY RESEARCH (2009)
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
Georg Lenz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The role of FDG-PET scans in patients with lymphoma
Pamela Seam et al.
BLOOD (2007)
Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma:: SUV-based assessment versus visual analysis
Chieh Lin et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Revised response criteria for malignant lymphoma
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Biological correlates of FDG uptake in non-small cell lung cancer
Lioe-Fee de Geus-Oei et al.
LUNG CANCER (2007)
[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma:: an early prognostic tool for predicting patient outcome
C Haioun et al.
BLOOD (2005)
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
CP Hans et al.
BLOOD (2004)
A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma
G Wright et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Differential FDG accumulation associated with GLUT-1 expression in a patient with lymphoma
H Koga et al.
ANNALS OF NUCLEAR MEDICINE (2003)
Share Paper
